Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trialDavid J. Kuter, Janet L. Nichol, Howard A. Liebman et al.|The Lancet|2008Cited by 862
Invasive fungal infections in acute myeloid leukemia treated with venetoclax and hypomethylating agentsIbrahim Aldoss, Vinod Pullarkat, Sanjeet Dadwal et al.|Blood Advances|2019Cited by 84
Outcome of Allogeneic Hematopoietic Cell Transplantation after Venetoclax and Hypomethylating Agent Therapy for Acute Myelogenous LeukemiaKaramjeet Sandhu, Vinod Pullarkat, Sanjeet Dadwal et al.|Biology of Blood and Marrow Transplantation|2020Cited by 43
Evaluation of AMG 531 Efficacy in Splenectomized Patients with Chronic Immune Thrombocytopenic Purpura (ITP) in a Randomized Placebo-Controlled Phase 3 Study.Terry Gernsheimer, Janet L. Nichol, Vinod Pullarkat et al.|Blood|2007Cited by 6
A Multicenter Analysis of Allogeneic Transplant Outcomes in Adults with Philadelphia-Like B-Cell Acute Lymphoblastic Leukemia in First Complete RemissionZaid Abdel Rahman, Partow Kebriaei, Tamer Othman et al.|Transplantation and Cellular Therapy|2024Cited by 6